FITLIFE BRANDS, INC. - Quarter Report: 2008 November (Form 10-Q)
U.S.
Securities and Exchange Commission
Washington,
D.C. 20549
____________________
FORM
10-Q
____________________
(Mark One)
the Securities Exchange Act of
1934
For the quarterly period ended
September 30, 2008
of the Securities Exchange
Act
For the transition period from
N/A to N/A
____________________
Commission File No. 333-137170
____________________
Bond
Laboratories, Inc.
(Name of
small business issuer as specified in its charter)
Nevada 20-3464383
State of
Incorporation IRS
Employer Identification No.
777
South Highway 101, Suite 215, Solana Beach, CA 92975
(Address
of principal executive offices)
(858) 847-9000
(Issuer’s
telephone number)
Securities
registered under Section 12(b) of the Exchange Act:
None
Securities
registered under Section 12(g) of the Exchange Act:
Common
Stock, $0.001 par value per share
(Title
of Class)
Indicate
by check mark whether the Registrant (1) has filed all reports required by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the Registrant was required
to file such reports) and (2) has been subject to such filing requirements
for the past 90 days: Yes x
No ¨
Indicate
by check mark whether the Registrant is a large accelerated filer, an
accelerated filer, or a non–accelerated filer. See definition of “accelerated
filer and large accelerated filer” in Rule 12b–2 of the Exchange Act. (Check
one):
Large
accelerated filer ¨ Accelerated
filer ¨ Non–Accelerated
filer ¨ Small Business
Issuer x
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b–2 of the Exchange Act). Yes ¨ No x
Transitional
Small Business Disclosure Format (check one): Yes No x
Indicate
the number of shares outstanding of each of the issuer’s classes of common
stock, as of the latest practicable date.
Class
|
Outstanding
at November 11, 2008
|
|
Common
stock, $0.001 par value
|
24,195,706
|
1
BOND
LABORATORIES, INC.
INDEX
TO FORM 10-QSB FILING
FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2008
TABLE OF CONTENTS
PART I
FINANCIAL INFORMATION PAGE
|
|
Page Numbers
|
||
PART
I - FINANCIAL INFORMATION
|
|
|||
Item 1.
|
|
Condensed
Consolidated Financial Statements
|
|
|
|
|
3
|
||
|
|
3
|
||
|
|
3
|
||
|
|
4
|
||
Item 2.
|
|
|
9
|
|
Item 3
|
|
|
15
|
|
Item 4.
|
|
|
15
|
|
PART
II - OTHER INFORMATION
|
|
|||
Item 1.
|
|
|
16
|
|
Item 1a
|
|
|
16
|
|
Item 2.
|
|
|
18
|
|
Item 3.
|
|
|
18
|
|
Item 4.
|
|
|
18
|
|
Item 5
|
|
|
19
|
|
Item 6.
|
|
|
19
|
CERTIFICATIONS
Exhibit
31 – Management certification……………………………………………………... 20-24
Exhibit 32 – Sarbanes-Oxley
Act……………………………………………………………..20-24
2
PART
I – FINANCIAL INFORMATION
ITEM
1 – FINANCIAL STATEMENTS
BOND
LABORATORIES, INC.
|
||||||||
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
||||||||
ASSETS:
|
||||||||
September
30, 2008
|
December
31, 2007
|
|||||||
(unaudited)
|
(audited)
|
|||||||
CURRENT
ASSETS
|
||||||||
Cash
|
$1,490,068 | $590,197 | ||||||
Accounts
receivables - net
|
315,373 | 4,532 | ||||||
Inventory
|
611,507 | |||||||
Prepaid
expenses and other current assets
|
150,000 | 624,527 | ||||||
Total
current assets
|
2,566,948 | 1,219,256 | ||||||
PROPERTY
AND EQUIPMENT, net
|
78,094 | 92,977 | ||||||
Deposits
|
5,727 | 2,727 | ||||||
TOTAL
ASSETS
|
$2,650,769 | $1,314,960 | ||||||
LIABILITIES
AND STOCKHOLDERS' EQUITY:
|
||||||||
CURRENT
LIABILITIES:
|
||||||||
Accounts
payable
|
$402,953 | $30,000 | ||||||
Accrued
expenses and other liabilities
|
2,180 | 253 | ||||||
Total
current liabilities
|
405,133 | 30,253 | ||||||
TOTAL
LIABILITIES
|
405,133 | 30,253 | ||||||
CONTINGENCIES
AND COMMITMENTS
|
||||||||
STOCKHOLDERS'
EQUITY:
|
||||||||
Preferred
stock, $.01 par value, 10,000,000 shares authorized;
|
||||||||
5,000,000
issued and outstanding
|
50,000 | 50,000 | ||||||
Common
stock, $.01 par value, 75,000,000 shares authorized;
|
||||||||
24,195,706
and 20,231,450 issued and outstanding
|
||||||||
as
of September 30, 2008 and December 31, 2007, respectively
|
241,957 | 202,314 | ||||||
Additional
paid-in capital
|
10,439,915 | 5,809,008 | ||||||
Accumulated
deficit
|
(8,486,236 | ) | (4,776,615 | ) | ||||
Total
stockholders' equity
|
2,245,636 | 1,284,707 | ||||||
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY
|
$2,650,769 | $1,314,960 | ||||||
The
accompanying notes are an integral part of these condensed consolidated
financial statements.
|
BOND
LABORATORIES, INC.
|
||||||||||||||||
CONDENSED
CONSOLIDATED STATEMENT OF OPERATIONS (unaudited)
|
||||||||||||||||
FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2008 AND
2007
|
||||||||||||||||
Three
Months
|
Nine
Months
|
|||||||||||||||
2008
|
2007
|
2008
|
2007
|
|||||||||||||
Revenue
|
$501,290 | $2,114 | $1,126,659 | $3,119 | ||||||||||||
Total
|
501,290 | 2,114 | 1,126,659 | 3,119 | ||||||||||||
Cost
of Goods Sold
|
294,886 | 759 | 598,803 | 1,067 | ||||||||||||
Gross
Profits
|
206,404 | 1,355 | 527,856 | 2,052 | ||||||||||||
OPERATING
EXPENSES:
|
||||||||||||||||
General
and administrative
|
298,267 | 237,935 | 1,622,730 | 594,044 | ||||||||||||
Selling
and marketing
|
890,485 | 47,263 | 2,523,322 | 84,623 | ||||||||||||
Depreciation
and amortization
|
4,953 | 3,715 | 16,602 | 13,762 | ||||||||||||
Research
and development
|
- | 84,660 | 120,634 | 148,419 | ||||||||||||
Total
operating expenses
|
1,193,705 | 373,573 | 4,283,288 | 840,848 | ||||||||||||
OPERATING
LOSS
|
(987,301 | ) | (372,218 | ) | (3,755,432 | ) | (838,796 | ) | ||||||||
OTHER
(INCOME) AND EXPENSES
|
||||||||||||||||
Interest
expense
|
- | - | - | 42,631 | ||||||||||||
Interest
income
|
(31,885 | ) | (3,805 | ) | (33,907 | ) | (6,574 | ) | ||||||||
Rental
income
|
- | (1,500 | ) | (11,903 | ) | (4,500 | ) | |||||||||
Total
other expense
|
(31,885 | ) | (5,305 | ) | (45,810 | ) | 31,557 | |||||||||
NET
LOSS
|
$(955,416 | ) | $(366,913 | ) | $(3,709,622 | ) | $(870,353 | ) | ||||||||
NET
LOSS PER SHARE:
|
||||||||||||||||
Basic
and diluted - loss per share
|
$(0.04 | ) | $(0.04 | ) | $(0.17 | ) | $(0.12 | ) | ||||||||
Basic
and diluted - weighted average
|
24,680,706 | 8,789,573 | 22,217,167 | 7,480,777 | ||||||||||||
The
accompanying notes are an integral part of these condensed consolidated
financial statements
|
BOND
LABORATORIES, INC.
|
||||
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
|
||||
FOR
THE NINE MONTHS ENDED SEPTEMBER 30, 2008 AND 2007
|
||||
2008
|
2007
|
|||
Net
(loss)
|
$ (3,709,622)
|
$ (870,353)
|
||
Adjustments
to reconcile net loss to net cash
|
||||
(used
in) operating activities:
|
||||
Depreciation
and amortization
|
16,602
|
13,762
|
||
Common
stock issued for compensation
|
1,423,264
|
7,925
|
||
Changes
in assets and liabilities:
|
||||
Accounts
receivables
|
474,527
|
(2,298)
|
||
Inventory
|
(611,507)
|
|||
Prepaid
expenses
|
-
|
12,592
|
||
Other
current assets
|
(310,841)
|
-
|
||
Deposits
|
(3,001)
|
(47,728)
|
||
Accounts
payables
|
372,954
|
-
|
||
Accrued
liabilities
|
1,927
|
15,020
|
||
Net
cash used in operating activities
|
(2,345,697)
|
(871,080)
|
||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
||||
Purchase
of intangible asset
|
(1,719)
|
(122,569)
|
||
Net
cash used in investing activities
|
(1,719)
|
(122,569)
|
||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
||||
Purchase
of common stock
|
3,498,000
|
700,892
|
||
Cost
of raising capital
|
(250,713)
|
-
|
||
Proceeds
from convertible notes payables
|
-
|
335,000
|
||
Net
cash provided by financing activities
|
3,247,287
|
1,035,892
|
||
INCREASE
IN CASH
|
899,871
|
42,243
|
||
CASH,
BEGINNING OF YEAR
|
590,197
|
60,753
|
||
CASH,
END OF YEAR
|
$ 1,490,068
|
$ 102,996
|
||
Supplemental
disclosure of non-cash investing and financing activities
|
||||
Issuance
of company stock for interest
|
$ -
|
$ 24,313
|
||
Conversion
of debt into company's common shares
|
$ -
|
$ 815,000
|
||
Issuance
of company stock for compensation
|
$ -
|
$ 230,000
|
||
Issuance
of company stock for notes payable affiliates
|
$ -
|
$ 119,606
|
||
The
accompanying notes are an integral part of these condensed consolidated
financial
statements
|
BOND
LABORATORIES, INC.
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2008 and 2007
NOTE
1 - DESCRIPTION OF BUSINESS
Bond
Laboratories, Inc. (“The Company”) was incorporated in the state of Nevada on
July 26, 2005. The Company has its wholly owned subsidiary Got
Fusion, Inc. that was incorporated in August of 2007 and was operating in the
nine months ended September 30, 2008. The Company is focused on the
development of fortified foods and beverage, in three major categories: energy
drinks, pain relief, and weight loss. Energy drinks were chosen as
the initial target category, as management deemed it to be the easiest barrier
to entry. Bond Labs develops and markets products that address the
constantly changing needs of consumers, and contracts out manufacturing and
fulfillment to keep margins high and overhead low. On November 8,
2007 Bond Laboratories launched the Fusion 2 ounce.6+ hr. energy shot at the
NACS show in Atlanta, Ga. Fusion has received orders and
subsequent re-orders from some of the biggest C-store chains, drug store chains,
sporting goods stores, casinos, and health clubs in the
nation. Fusion has also established relationships with all of the
nation’s largest distributors. Bond Laboratories, Inc.
now trades under the symbol BNLB.OB on the OTC:BB market.
NOTE
2 - BASIS OF PRESENTATION
Interim Financial
Statements
The
accompanying interim unaudited condensed consolidated financial statements have
been prepared in accordance with generally accepted accounting principles for
interim financial information and with the instructions to Form 10-Q and Article
8 of Regulation S-X. Accordingly, they do not include all of the information and
footnotes required by generally accepted accounting principles for complete
financial statements. In our opinion, all adjustments (consisting of normal
recurring accruals) considered necessary for a fair presentation have been
included. Operating results for the three and nine months period ended September
30, 2008 are not necessarily indicative of the results that may be expected for
the year ending December 31, 2008. For further information, refer to the
financial statements and footnotes thereto included in our Form 10-KSB Report
for the fiscal year ended December 31, 2007.
NOTE
3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Critical
Accounting Policies
We
prepare our consolidated financial statements in accordance with accounting
principles generally accepted in the United States of America. The preparation
of these financial statements requires the use of estimates and assumptions that
affect the reported amounts of assets and liabilities and the disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amount of revenues and expenses during the reporting period. Our
management periodically evaluates the estimates and judgments made. Management
bases its estimates and judgments on historical experience and on various
factors that are believed to be reasonable under the circumstances. Actual
results may differ from these estimates as a result of different assumptions or
conditions.
Accounting
Policies and Estimates
The
preparation of our financial statements in conformity with accounting principles
generally accepted in the United States of America requires our management to
make certain estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at
the date of the financial statements and the reported amounts of revenues and
expenses during the reporting period. Our management periodically
evaluates the estimates and judgments made. Management bases its estimates and
judgments on historical experience and on various factors that are believed to
be reasonable under the circumstances. Actual results may differ from these
estimates as a result of different assumptions or conditions.
As such,
in accordance with the use of accounting principles generally accepted in the
United States of America, our actual realized results may differ from
management’s initial estimates as reported. A summary of significant
accounting policies are detailed in notes to the financial statements which are
an integral component of this filing.
Revenue
Recognition
Revenue
from product sales is recognized upon shipment to customers at which time such
customers are invoiced. Units are shipped under the terms of FOB
shipping point when determination is made that collectibility is
probable. Revenues for services are recognized upon completion of the
services. For consulting services and other fee-for-service
arrangements, revenue is recognized upon completion of the
services. The Company has adopted the Securities and Exchange
Commission’s Staff Accounting Bulletin (SAB) No. 104, which provides guidance on
the recognition, presentation and disclosure of revenue in financial
statements.
Recent Accounting Pronouncements
Determining
Whether Instruments Granted in Share-Based Payment Transactions Are
Participating Securities
In
June 2008, the FASB issued FSP Emerging Issues Task Force (“EITF”) Issue
No. 03-6-1, “Determining Whether Instruments Granted in Share-Based Payment
Transactions Are Participating Securities.” The FSP addresses whether
instruments granted in share-based payment transactions are participating
securities prior to vesting and, therefore, need to be included in the earnings
allocation in computing earnings per share under the two-class method. The FSP
affects entities that accrue dividends on share-based payment awards during the
awards’ service period when the dividends do not need to be returned if the
employees forfeit the award. This FSP is effective for fiscal years beginning
after December 15, 2008. The Company is currently assessing the impact of
FSP EITF 03-6-1 on its consolidated financial position and results of
operations.
3
Determining
Whether an Instrument (or an Embedded Feature) Is Indexed to an entity's Own
Stock
In June
2008, the FASB ratified EITF Issue No. 07-5, "Determining Whether an Instrument
(or an Embedded Feature) Is Indexed to an Entity's Own Stock" (EITF
07-5). EITF 07-5 provides that an entity should use a two step
approach to evaluate whether an equity-linked financial instrument (or embedded
feature) is indexed to its own stock, including evaluating the instrument's
contingent exercise and settlement provisions. It also clarifies on
the impact of foreign currency denominated strike prices and market-based
employee stock option valuation instruments on the evaluation. EITF
07-5 is effective for fiscal years beginning after December 15,
2008. The Company is currently assessing the impact of EITF 07-5 on
its consolidated financial position and results of operations.
Accounting
for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (
Including Partial Cash Settlement)
In
May 2008, the FASB issued FSP Accounting Principles Board (“APB”) Opinion
No. 14-1, “Accounting for Convertible Debt Instruments That May Be
Settled in Cash upon Conversion (Including Partial Cash Settlement).” The FSP
clarifies the accounting for convertible debt instruments that may be settled in
cash (including partial cash settlement) upon conversion. The FSP
requires issuers to account separately for the liability and equity components
of certain convertible debt instruments in a manner that reflects the issuer's
nonconvertible debt (unsecured debt) borrowing rate when interest cost is
recognized. The FSP requires bifurcation of a component of the debt,
classification of that component in equity and the accretion of the resulting
discount on the debt to be recognized as part of interest expense in our
consolidated statement of operations. The FSP requires retrospective
application to the terms of instruments as they existed for all periods
presented. The FSP is effective as of January 1, 2009 and early
adoption is not permitted. The Company is currently evaluating the
potential impact of FSP APB 14-1 upon its consolidated financial
statements.
The
Hierarchy of Generally Accepted Accounting Principles
In May
2008, the FASB issued SFAS No. 162, "The Hierarchy of Generally Accepted
Accounting Principles" (FAS No.162). SFAS No. 162 identifies the
sources of accounting principles and the framework for selecting the principles
used in the preparation of financial statements. SFAS No. 162 is
effective 60 days following the SEC's approval of the Public Company Accounting
Oversight Board amendments to AU Section 411, "The Meaning of Present Fairly in
Conformity with Generally Accepted Accounting Principles". The
implementation of this standard will not have a material impact on the Company's
consolidated financial position and results of operations.
Determination
of the Useful Life of Intangible Assets
In April
2008, the FASB issued FSP FAS No. 142-3, “Determination of the Useful Life of
Intangible Assets”, which amends the factors that should be considered in
developing renewal or extension assumptions used to determine the useful life of
intangible assets under SFAS No. 142 “Goodwill and Other Intangible
Assets”. The intent of this FSP is to improve the consistency between the
useful life of a recognized intangible asset under SFAS No. 142 and the period
of the expected cash flows used to measure the fair value of the asset under
SFAS No. 141 (revised 2007) “Business Combinations” and other U.S. generally
accepted accounting principles. The Company is currently
evaluating the potential impact of FSP FAS No. 142-3 on its consolidated
financial statements.
4
Disclosure
about Derivative Instruments and Hedging Activities
In March
2008, the FASB issued SFAS No. 161, “Disclosure about Derivative
Instruments and Hedging Activities, an amendment of SFAS No.
133”, (SFAS No.161). This statement requires that objectives for using
derivative instruments be disclosed in terms of underlying risk and accounting
designation. The Company is required to adopt SFAS No. 161 on January 1, 2009.
The Company is currently evaluating the potential impact of SFAS No. 161 on the
Company’s consolidated financial statements.
Delay
in Effective Date
In
February 2008, the FASB issued FSP FAS No. 157-2, “Effective Date of FASB
Statement No. 157”. This FSP delays the effective date of SFAS No. 157 for
all nonfinancial assets and nonfinancial liabilities, except those that are
recognized or disclosed at fair value on a recurring basis (at least annually)
to fiscal years beginning after November 15, 2008, and interim periods
within those fiscal years. The impact of adoption was not material to the
Company’s consolidated financial condition or results of
operations.
Business
Combinations
In
December 2007, the FASB issued SFAS No. 141(R) “Business Combinations” (SFAS
141(R)). This Statement replaces the original SFAS No.
141. This Statement retains the fundamental requirements in SFAS
No. 141 that the acquisition method of accounting (which SFAS No. 141
called the purchase method) be used for all business combinations and for an
acquirer to be identified for each business combination. The objective of SFAS
No. 141(R) is to improve the relevance, and comparability of the information
that a reporting entity provides in its financial reports about a business
combination and its effects. To accomplish that, SFAS No. 141(R) establishes
principles and requirements for how the acquirer:
a.
|
Recognizes
and measures in its financial statements the identifiable assets acquired,
the liabilities assumed, and any noncontrolling interest in the
acquiree.
|
b.
|
Recognizes
and measures the goodwill acquired in the business combination or a gain
from a bargain purchase.
|
c.
|
Determines
what information to disclose to enable users of the financial statements
to evaluate the nature and financial effects of the business
combination.
|
This
Statement applies prospectively to business combinations for which the
acquisition date is on or after the beginning of the first annual reporting
period beginning on or after December 15, 2008 and may not be applied before
that date. The Company does not expect the effect that its adoption of SFAS No.
141(R) will have on its consolidated results of operations and financial
condition.
Noncontrolling
Interests in Consolidated Financial Statements—an amendment of ARB No.
51
In
December 2007, the FASB issued SFAS No. 160 “Noncontrolling Interests in
Consolidated Financial Statements – an amendment of ARB No. 51” (SFAS No.
160). This Statement amends the original Accounting Review Board
(ARB) No. 51 “Consolidated Financial Statements” to establish accounting and
reporting standards for the noncontrolling interest in a subsidiary and for the
deconsolidation of a subsidiary. It clarifies that a noncontrolling interest in
a subsidiary is an ownership interest in the consolidated entity that should be
reported as equity in the consolidated financial statements. This Statement is
effective for fiscal years and interim periods within those fiscal years,
beginning on or after December 15, 2008 and may not be applied before that
date. The does not expect the effect that its adoption of SFAS No.
160 will have on its consolidated results of operations and financial
condition.
5
Fair
Value Option for Financial Assets and Financial Liabilities
In
February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for
Financial Assets and Financial Liabilities – Including an amendment of SFAS No.
115” (SFAS No. 159), which becomes effective for the Company on February 1,
2008, permits companies to choose to measure many financial instruments and
certain other items at fair value and report unrealized gains and losses in
earnings. Such accounting is optional and is generally to be applied instrument
by instrument. The Company does not anticipate that the election, of this
fair-value option will have a material effect on its consolidated financial
condition, results of operations, cash flows or disclosures.
Fair
Value Measurements
In
September 2006, the FASB issued SFAS No. 157, "Fair Value Measurements" (SFAS
No. 157). SFAS No. 157 provides guidance for using fair value to measure assets
and liabilities. SFAS No. 157 addresses the requests from investors for expanded
disclosure about the extent to which companies’ measure assets and liabilities
at fair value, the information used to measure fair value and the effect of fair
value measurements on earnings. SFAS No. 157 applies whenever other standards
require (or permit) assets or liabilities to be measured at fair value, and does
not expand the use of fair value in any new circumstances. SFAS No. 157 is
effective for financial statements issued for fiscal years beginning after
November 15, 2007 and will be adopted by the Company in the first quarter of
fiscal year 2008. The Company is unable at this time to determine the effect
that its adoption of SFAS No. 157 will have on its consolidated results of
operations and financial condition.
NOTE
4 - RELATED PARTY TRANSACTIONS
Bond is
managed by its key shareholder and as of September 30, 2008 its officer and
director. This shareholder is a sole shareholder of Small World
Traders.
NOTE
5 - NET LOSS PER SHARE
Restricted
shares and warrants are not included in the computation of the weighted average
number of shares outstanding during the periods. There are no
restricted shares or warrants issued in the capital of the
Company. The net loss per common share is calculated by dividing the
consolidated loss by the weighted average number of shares outstanding during
the periods.
NOTE
6 - EQUITY
During
nine months ended September 30, 2008 and 2007:
Quarter Ended | Stock issued | Cash Received | Stock for | Stock issued and |
for Cash | Conversion of | cancelled for | ||
Dept | services | |||
March 31, 2007 |
|
-
|
1,878,600 | - |
June 30, 2007 | 607,500 | $ 595,891 |
-
|
708,625 |
September 30, 2007 | 105,000 | 105,000 | - | 817,500 |
Total Issued | 712,500 | $ 700,891 | 1,878,600 | 1,526,125 |
March 31, 2008 | 388,000 | $ 388,000 |
-
|
(439,500) |
June 30, 2008 | 3,254,456 | 3,110,000 | - | 1,246,300 |
September 30, 2008 |
-
|
- | - | (485,000) |
Total Issued | 3,642,456 | $ 3,498,000 | - | 321,800 |
6
During
the three months ended March 31, 2007, the Company issued 1,238,600 shares of
its common stock for the conversion of debt in the amount of $815,000 plus
accrued interest of $24,313 with the total conversion of
$839,313. The company issued 230,000 common shares for the conversion
of debt from the accrued salary of the company’s CEO of
$230,000. Also the Company issued 200,000 common shares for the
conversion of affiliate debt of $119,606. The Company agreed to
convert all remaining debt of the company to solidify the financial
presentation. The Company did not receive proceeds from this
conversion of debt. The Company converted debt from prior periods
which this conversion is a non-cash transaction as reflected in the statement of
Cash Flow.
During
the three months ended September 30, 2007, the Company issued 607,500 shares of
its common stock for $595,891. The Company issued shares of its common stock as
consideration to consultants for the fair value of the services rendered. The
value of those shares is determined based on the trading value of the stock at
the dates on which the agreements were entered into for the services and the
value of service rendered. During the period ended September 30, 2008, the
Company granted to consultants, 708,625 shares of common stock valued at par
value since the stock did not have a trading symbol. The value of these shares
issued were expensed in the period incurred.
During
the three months ended September 30, 2007, the Company issued 105,000 shares of
its common stock for $105,000. The Company has issued shares of its common stock
as consideration to consultants for the fair value of the services rendered. The
value of those shares is determined based on the trading value of the stock at
the dates on which the agreements were entered into for the services and the
value of service rendered. During the period ended September 30, 2007, the
Company granted to consultants, 817,500 shares of common stock valued at par
value since the stock did not have a trading symbol. The value of these shares
issued were expensed in the period incurred.
There
were no options granted in the nine months ended September 30,
2007.
During
the three months ended March 31, 2008, the Company issued 388,000 shares of its
common stock for $388,000. The Company has issued 308,000 shares of
its common stock as consideration to consultants for the fair value of the
services rendered. The value of those shares is determined based on
the trading value of the stock at the dates on which the agreements were entered
into for the services and the value of service rendered. During
the period ended March 31, 2008, the Company cancelled 747,500 shares of common
stock valued at par value since the stock did not have a trading
symbol. The value of these shares issued were expensed in the period
incurred.
During
the three months ended September 30, 2008, the Company issued 3,254,456 shares
of its common stock for $3,110,000. The Company has issued 1,246,300
shares of its common stock as consideration to consultants for the fair value of
the services rendered. The company cancelled 485,000 common
shares. The value of those shares is determined based on the trading
value of the stock at the dates on which the agreements were entered into for
the services and the value of service rendered. The value of
these shares issued were expensed in the period incurred.
The
Company issued 3,000,000 of its shares in a private placement memorandum that
funded the Company on June 26, 2008. The Company had cost of raising
capital of $250,713 that was paid to brokers and attorneys. The
Company issued 1,800,000 warrants as the cost of raising capital that had a
strike price of $1.25.
There
were no options granted in the nine months ended September 30,
2008. The Company had a total of 3,038,600 warrants outstanding as of
September 30, 2008 with 1,238,600 having a strike price of $1.00 and 1,800,000
having a strike price of $1.25. These warrants have a five year life
which expires 2012 and 2013 respectively.
7
NOTE
7 – SUBSEQUENT EVENTS
On
October 1, 2008, we executed and closed an asset purchase agreement (the
"Agreement") with NDS Nutritional Products, Inc., a Nebraska corporation ("NDS
Nutritional Products") and the principles, whereby pursuant to the terms and
conditions of that Agreement, we acquired the assets, properties and rights of
NDS Nutritional Products relating to the business of NDS Nutritional Products
(except for certain excluded assets as disclosed in the Agreement). In addition,
we assumed certain liabilities, as disclosed in the Agreement.
As
consideration for the purchase of the assets, we agreed to pay Seven Hundred
Thousand Dollars ($700,000) in cash, Three Hundred Fifty Thousand Dollars
($350,000) in the form of a secured promissory note payable in eighteen (18)
fixed monthly installments and accruing interest at the rate of six percent (6%)
per annum, an amount equal to the book value of those fixed assets of NDS
Nutritional Products, in the form of a secured promissory note (the amount of
which will be determined prior to Closing), an earn-out payment in the amount of
Three Hundred Fifty Thousand Dollars ($350,000) (subject to certain adjustments
as disclosed in the Agreement), payable in six (6) consecutive, equal, quarterly
installments, an amount equal to the book value of the product inventory of NDS
Nutritional Products which consists of component parts (i.e., lids, labels,
bottles, boxes, packaging, etc, in the form of a secured promissory note,
payable in twelve (12) fixed monthly installments and accruing interest at the
rate of six percent (6%) per annum(the amount of which will be determined prior
to Closing), and the issuance by the Company of One Million Five Hundred Fifty
Thousand (1,550,000) shares of unregistered Common Stock, par value $0.001 per
share, of the Company, which shares company stock shall have such transfer
rights and be subject to certain restrictions on resale and transfer as set
forth in the Agreement and in that certain Stock Rights and Restriction
Agreement by and among the Company, NDS Nutritional Products Seller, the
principles, and certain Company Shareholders.
The
issuance of the securities above were effected in reliance on the exemptions for
sales of securities not involving a public offering, as set forth in Rule 506
promulgated under the Securities Act of 1933, as amended (the "Securities Act")
and in Section 4(2) and Section 4(6) of the Securities Act and/or Rule 506 of
Regulation D.
ITEM
2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
Management’s
Discussion and Analysis contains various “forward looking statements” within the
meaning of Section 21E of the Securities Exchange Act of 1934, as amended,
regarding future events or the future financial performance of the Company that
involve risks and uncertainties. Certain statements included in this Form
10-QSB, including, without limitation, statements related to anticipated cash
flow sources and uses, and words including but not limited to “anticipates”,
“believes”, “plans”, “expects”, “future” and similar statements or expressions,
identify forward looking statements. Any forward-looking statements herein are
subject to certain risks and uncertainties in the Company’s business, including
but not limited to, reliance on key customers and competition in its markets,
market demand, product performance, technological developments, maintenance of
relationships with key suppliers, difficulties of hiring or retaining key
personnel and any changes in current accounting rules, all of which may be
beyond the control of the Company. The Company adopted at management’s
discretion, the most conservative recognition of revenue based on the most
astringent guidelines of the SEC in terms of recognition of software licenses
and recurring revenue. Management will elect additional changes to revenue
recognition to comply with the most conservative SEC recognition on a forward
going accrual basis as the model is replicated with other similar markets (i.e.
SBDC). The Company’s actual results could differ materially from those
anticipated in these forward-looking statements as a result of certain factors,
including those set forth therein.
8
Forward-looking
statements involve risks, uncertainties and other factors, which may cause our
actual results, performance or achievements to be materially different from
those expressed or implied by such forward-looking statements. Factors and risks
that could affect our results and achievements and cause them to materially
differ from those contained in the forward-looking statements include those
identified in the section titled “Risk Factors” in the Company’s Annual Report
on Form 10-KSB for the year ended December 31, 2007, as well as other factors
that we are currently unable to identify or quantify, but that may exist in the
future.
In
addition, the foregoing factors may affect generally our business, results of
operations and financial position. Forward-looking statements speak only as of
the date the statement was made. We do not undertake and specifically decline
any obligation to update any forward-looking statements.
Overview
With the
advent of the internet and the subsequent exponential flow of unlimited
information, lifestyles changes have unquestionably increased far more than that
in the most recent 20 years. The end effect this has had on lifestyle
changes and products that support that lifestyle change cannot be
overstated. The result is a lifestyle that moves faster than thought
possible just ten years ago and a generation that embraces products that enable
them not just to keep up, but to thrive in this rapidly developing environment.
Recent examples of these changes are as follows:
·
|
Thirsty...why
drink a 16 once carbonated drink when you can drink an energy drink that
contains essential vitamins?
|
·
|
Hungry…why
eat regular cereal loaded with sugar when you can eat cereal fortified
with 50% of your daily recommended
vitamins?
|
Capitalizing
on this fast moving trend, Bond Laboratories brought together a veteran team of
seasoned individuals with a solid track record of converting ideas into highly
profitable, consumption-driven products. Bond’s goal is to be on the leading
edge of innovation. Bond is now pursuing its unique vision for the
next generation of preventative health products; Healthy Beverages and
Foods.
Convenience:
The demand for easier, faster, quicker acting and disposable products has
been the mantra of consumers in the United states and throughout the world.
Convenience, time saving products, and “quick fixes” are important to 82% of
European and U.S. consumers. Convenience is also impacting personal care
consumption; 57% of European and U.S. consumers report that they groom while
on-the-move and 58% admit to grooming at-work. Bond Laboratories is ideally
positioned to leverage the opportunity of providing products to this broad
consumer base.
Bond
Laboratories is set up to cater to all five of the major distribution channels;
focusing on the three most profitable categories of the industry- Energy, Pain
Relief and Weight loss. Based upon our extensive research, we strongly believe
that our liquid energy product would make for an extremely successful initial
product offering to the public markets.
Initial
Target Market: Energy
Product:
Fusion 6+ Hour Energy Shot
According
to the Beverage Marketing Corporation (2007), the market for energy drinks in
2006 exceeded $2.5 billion, which represented a 516% gain from
2000. New product introductions, have numbered in the hundreds,
accounted for a significant percentage of the sales growth. The
principal marketing channels in 2006 were convenience/gasoline stores (35.7%),
mass merchandisers (16.5%), and supermarkets (11.3%), with most of the growth
occurring in mass merchandiser and supermarket channels.
9
Energy
"Shots" have been particularly successful since their launch in 2004, rapidly
growing to 11.7% of total energy drink spending. Benefits include
convenient portability (small size), less carbohydrates and sugar than
full-sized drinks, added vitamins and minerals, easy consumption of the small
volume of liquid (two ounces), and no need for
refrigeration. Retailers enjoy the small footprint of the marketing
cubes, high margins, and rapid inventory turns. The small footprint
allows retailers to merchandise the shots in high-impulse
locations.
The
significance of being one of the first brands to market cannot be
overlooked. Energy Drinks began their popularity with products like
Red Bull in the late 1980’s. Although there are over 600 energy
drinks on the market today, it is estimated that Red Bull sold over 5 Billion
units in 2007. The concentrated 2 ounce energy shot drink began
approximately 3 years ago with about 30 brands in the category today; the first,
‘5 Hour Energy’ is expected to have had sales of well in excess of $100 million
for 2007. Bond launched its Fusion 6+ Hour Energy Shot at the
National Association of Convenience Stores in November of 2007 where it was
voted Best Taste.
Fusion 6+ Hour Energy Shot
Product Features:
•
|
3X
the kick of the typical canned energy drink in a small 2oz.
bottle!
|
•
|
Metabolizes
faster than canned energy
drink
|
•
|
Zero carbs, Zero
grams of sugar, only 8 calories per
serving
|
•
|
No
crash- as associated with all sugar based energy
drinks
|
•
|
The
strongest / longest lasting energy shot available on the
market
|
•
|
Voted
the #1 tasting energy shot in the category at the 2007 NACS
Show!
|
Available
in Berry and Limon
Retailers
have found that the energy shot product category is #1 in both dollar sales at
the front-end checkout and in dollar sales per square inch of display
space. (Source: A.C. Nielsen, May 2007). A 6-piece counter
display for Fusion® is 12.75 square inches, and a 12-piece counter display is
25.9 square inches). Fusion® also has an attractive gross profit for
the retailer. With a regular wholesale price of $1.50 per unit and a
suggested retail price of $2.99, the retailer's gross profit is
49.8%.
Recent
Developments
NDS
Nutritional Products, Inc.
In
October 1, 2008 we purchased the entire interest of NDS Nutritional Products,
Inc. (“NDS” or “NDS Nutritional Products, Inc”) NDS Nutritional
Products, Inc was formed in 2001. NDS Nutritional Products, Inc is a
wholesaler and distributor of nutritional products focusing on Weight Loss,
Sports Nutrition and General Health. Falling under NDS Nutritional Products, Inc
are the Release Weight Loss line sold exclusively to GNC, the Professional
Muscular Development line sold exclusively to GNC, the Dr. Health line sold
exclusively to GNC, and the Infinite Labs product line sold through Distributors
and large retailers in the United States, Canada, and Europe.
10
NDS
Nutritional Products has a strong history and brings tremendous resources to our
organization. Established in 1998, NDS focuses its dynamic capabilities on
providing cutting-edge quality products in the weight loss, sports nutrition and
general health categories. Its emphasis is placed on the education of the
consumer in regards to the unique attributes of its diverse product line. Its
strength is in the health and nutrition channel, which will nicely complement
our current, rapidly growing retail distribution network in convenience stores
and mass. We have built this growing network through the introduction of our
first offering, the Fusion 6+ Hour 2 oz. Energy Shot.
NDS
Nutritional Products, Inc. is the first of what management believes
will be numerous acquisitions that will help us accomplish that goal. NDS is
strategically involved with the development of the next generation of
preventative health products, Fortified Foods and Beverages. Management believes
NDS is an appropriate fit for our company as we .anticipate, but
cannot guarantee, will immediately add significant revenue to our top
line and be accretive to our earnings next year. We will integrate NDS
distribution in the health and the nutrition channel alongside our rapidly
growing retail distribution network in convenience stores (C-stores). Not only
will the NDS acquisition allow us to add 40 additional SKUs in the fast growing
sports nutrition market for our International broker network, we have gained a
centralized infrastructure in Omaha, NE.
Competition
Management
anticipates that we will encounter competition in each market that we
enter. Patent and Trademark applications that cover new embodiments
of technology will be pursued wherever possible. While we cannot
assure that the patents and applications will block competitive products, they
should help us become a significant participant in the marketplace.
The
industry leader is Red Bull with annual sales of approximately $5
billion. The other leaders in the category include Monster,
(manufactured and distributed by Hanson Beverages), RockStar, (now distributed
by Coca Cola along with its own brand ‘Full Throttle’), Amp, (manufactured and
distributed by Pepsi) and SoBe, (also manufactured and distributed by
Pepsi). To managements’ knowledge and observation, almost
all energy products are sold in 8 – 24 ounce cans. As of the end of
2007, there were more than 600 brands in the energy can drink business, with
close to 200 going out of business that year and 200 new entries to take their
place. Fusion is sold in a 2 ounce shot with the same ‘kick’ as a 24
ounce energy drink. This gives ‘Fusion’ a major advantage that is
stressed to the consumers in all marketing materials. Not only is it
easier to carry around a small bottle, vs. several cans, (which must stay cold),
but cans use science and technology from over ten years ago. Where
the energy can market is dominated by major brands with sales exceeding $500 mm
- $5 billion, the shot market only has approximately 30 brands, of which only
one, 5 Hour Energy, has sales exceeding $100 mm. Since 1995, there
have been great discoveries in energy producing nutrients. More
important, studies have clearly demonstrated that most ingredients are not
stable in normal carbonated beverage products and that the longer they stay in
contact with liquid, the less potent they become.
Marketing
Program
The
Company has worked hard to establish a ‘Premium’ Brand
image. Consistent with this has been the sponsorship of elite
athletes who have achieved champion status in their individual
specialties.
2008 -
L&M Racing: Competing in Supercross Motorcycle racing, L&M has two
racers, Chad Reed and Nathan Ramsey. For the 2008 season, Chad
Reed was the world champion winning 11 of 18 races. Nathan
Ramsey placed 6th place
overall. The Fusion logo was prominently displayed on jerseys,
motorcycles, the team rig and hats as well as the water bottle held on the
podium. Races were broadcast on Speed TV and CBS.
11
2008-2009
– Tara Dakides: Tara is recognized as the most accomplished female snowboarder
ever. She competes in numerous events every year including the Winter
X games which is broadcast on national television. In addition,
during the warmer months, Tara competes on the only all women Baja 1000 team and
CORR, (Champion Off Road Racing), seen on Speed TV and NBC. The
Fusion logo was prominently displayed on jerseys, her snowboard, the team rig,
hats and cars as well as the water bottle held on the podium.
2008 –
Steve McCann: Steve is a worldwide recognized BMX rider who competes in the Dew
Tour, the X Games, the US Open and several other events that are picked up by
national broadcasters. He is the 1st athlete
in history to make the finals in every BMX specialty on the Dew Tour,
ever. The Fusion logo was prominently displayed on the helmet as well
as the water bottle held on the podium.
2008
- Darrell Lanigan: Amazing Consistency Propelled Darrell Lanigan To
First Career World of Outlaws Late Model Series Championship In
2008. Lanigan’s sparkling ’08 stats show two wins, 25 top-five and 36
top-10 finishes in 43 A-Mains, plus one fast time honor and 17 heat-race wins.
He led 168 laps and completed 2,254 of a possible 2,285 laps, with only three of
the 31 laps he missed coming in full-points races.
2008-2009
– Jason Ellis: Skate, MMA, Drift car and Radio personality. Jason
competes at several events throughout the year in his various disciplines, but
his greatest value to the Company comes as a radio personality on Sirius
Satellite radio where he can be heard Monday-Friday for 3 hours per day focusing
on Action Sports and the athletes who compete in them. His estimate
audience is 500K – 1 million listeners per day.
2008 –
“Ruthless” Robbie Lawler: Mixed Martial Arts, (MMA). Robbie is the Elite XC
Middleweight Champion having won his most recent match against Scott
Smith on CBS Saturday night fights, broadcast on July 26th
nationwide. The Fusion logo was prominently displayed on the middle
of his shorts where it could be seen for a good portion of the
fight.
Revenues
Revenue
from product sales is recognized upon shipment to customers at which time such
customers are invoiced. Units are shipped under the terms of FOB
shipping point when determination is made that collectibility is
probable. Revenues for services are recognized upon completion of the
services. For consulting services and other fee-for-service
arrangements, revenue is recognized upon completion of the
services. Our company has adopted the Securities and Exchange
Commission’s Staff Accounting Bulletin (SAB) No. 104, which provides guidance on
the recognition, presentation and disclosure of revenue in financial
statements.
Additional
Information
We file
reports and other materials with the Securities and Exchange
Commission. These documents may be inspected and copied at the
Securities and Exchange Commission, Judiciary Plaza, 100 F Street, N.E., Room
1580, and Washington, D.C. 20549. You can obtain information on the
operation of the Public Reference Room by calling the Commission at
1-800-SEC-0330. You can also get copies of documents that the Company
files with the Commission through the Commission’s Internet site at www.sec.gov.
12
Results
of Operations
Revenues
for the three months ended September 30, 2008 increased to $501,290 from
$2,114 for the three months ended September 30, 2007 respectively. Revenues
for the nine months ended September 30, 2008 increased to $1,126,659 from $3,119
for the nine months ended September 30, 2007 respectively. Our future revenue
plan is dependent on our ability to effectively introduce our products to our
target consumers, generate sales, and obtain contract manufacturing
opportunities. We have introduced our new products for Go Fusion
which has increased our revenues for the three and nine months ended September
30, 2008.
General
and administrative expenses for the three months ended September 30, 2008
increased to $298,267 from $237,935 for three months ended September 30,
2007. General and administrative expenses for nine months ended
September 30, 2008 increased to $1,622,730 from $594,044 the nine months ended
September 30, 2007, respectively. The increase in general and
administrative expenses relates to employing full time employees and officers
during 2007 and 2008, and relates to increased costs of being a public reporting
company, including costs associated with our filings with the U.S. Securities
and Exchange Commission which matches with our overall business
plan.
Selling
and marketing expenses for three months ended September 30, 2008 increase to
$890,485 from $47,263 for three months ended September 30,
2007. Selling and marketing expenses for nine months ended September
30, 2008 increased to $2,523,322 from $84,623 for the nine months ended
September 30, 2007, respectively. The increase in sales and marketing
services relates to costs associated with hiring investor relations firms,
marketing firms, advertising firms, company sponsors, and stock related services
also increased travel to promote the sales of our products. Our
advertising expenses for the nine months end of $2,265,322 as the Company has
implemented its marketing and sponsorship plan. In the three months
ended September 30, 2008, we issued 680,000 in common stock for sponsorship of
our products which was valued at $1.00 per shares and represented of the
increase in selling and marketing expenses. We also paid nearly
$400,000 in marketing expenses with Wasserman Media. In addition, we
recognized the prepaid sponsorship of $450,000 that was accrued from prior
year.
Depreciation
and amortization for three months ended September 30, 2008 increased to $4,953
from $3,715 for three months ended September 30, 2007. Depreciation
and amortization expenses for nine months ended September 30, 2008 increased to
$16,602 from $13,762 for the nine months ended September 30, 2007,
respectively. The increase in depreciation and amortization relates
to the purchase of new equipment to prepare our product associated with our
marketing plan.
Research
and development for three months ended September 30, 2008 decreased to $0.00
from $84,660 for three months ended September 30, 2007. Research and
development for nine months ended September 30, 2008 decreased to $120,634 from
$148,419 for the nine months ended September 30, 2007,
respectively. The decrease in research and development relates to
increase in our business model to develop and product our products for
consumption and sales to the general public for increase healthiness and
energy.
We
incurred losses of approximately $955,416, and $366,913 for the three months
ended September 30, 2008 and 2007, respectively and incurred losses of
$3,709,621 and $870,353 for the nine months ended September 30, 2008 and 2007,
respectively. Our losses since our inception through September 30,
2008 amount to $8,486,236. The increase in the loss reflects our
investment in product development, packaging, contract manufacturing and
marketing.
Liquidity
and Capital Resources
We have
maintained a minimum of three months of working capital in the bank since
September of 2005. This reserve was intended to allow for an adequate
amount of time to secure additional funds from investors as
needed. To date, management has succeeded in securing capital as
needed. Our monthly cash requirement amount is approximately
$125,000. Based on our recent financing, we have over 18 months worth
of working capital in the bank. During the nine months ended
September 30, 2008, we sold 3,642,456 common shares for $3,498,000.
13
Our cash
used in operating activities is $2,345,697 and $871,080 in the nine months ended
September 30, 2008 and 2007 respectively. The increase is mainly
attributable to the increase in operating expenses in the current
year.
Cash used
by investing activities was $1,719 and $122,569 for the nine months ended
September 30, 2008 and 2007, respectively. The decrease is due to a decrease in
purchase of equipment to develop our products.
Cash
provided by financing activities was $3,247,287 and $1,035,892 for the nine
months ended September 30, 2008 and 2007, respectively. The increase is due to
an increase in raising funds from our shareholders to develop our products for
sale in the market. We sold stock and received proceeds of $3,498,000
and had cost of capital of $250,713 for the nine months ended September 30, 2008
as compared to $335,000 in the proceeds from convertible notes payable and sold
stock and received precedes $700,892 for the nine months ended September 30,
2007.
In the
quarter ended March 31, 2007 our convertible debt holders converted to
equity. We converted $839,313 of convertible debt to
1,238,600 of our common shares. Our CEO has converted the accrued
salary of $230,000 to 230,000 common shares. Small World Traders had
an outstanding debt of $119,606, and chose to convert this outstanding debt to
200,000 of our common shares. The conversion of this debt was a non
cash transaction.
14
We do not
hold any derivative instruments and do not engage in any hedging activities.
Most of our activity is the sale of our nutricutical products.
ITEM
4. CONTROLS AND PROCEDURES
a)
Evaluation of Disclosure Controls and Procedures
Our Chief
Executive Officer and Chief Financial Officer evaluated the effectiveness of our
disclosure controls and procedures as of the end of the period covered by this
report. Based on that evaluation, Chief Executive Officer and Chief Financial
Officer concluded that our disclosure controls and procedures as of the end of
the period covered by this report were effective such that the information
required to be disclosed by us in reports filed under the Securities Exchange
Act of 1934 is (i) recorded, processed, summarized and reported within the time
periods specified in the SEC's rules and forms and (ii) accumulated and
communicated to the Chief Executive Officer and Chief Financial Officer, as
appropriate to allow timely decisions regarding disclosure. A controls system
cannot provide absolute assurance, however, that the objectives of the controls
system are met, and no evaluation of controls can provide absolute assurance
that all control issues and instances of fraud, if any, within a company have
been detected.
Our
Chief Executive Officer and Chief Financial Officer is responsible for
establishing and maintaining adequate internal control over financial reporting
(as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over
financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with accounting
principles generally accepted in the United States.
Because
of its inherent limitations, internal control over financial reporting may not
prevent or detect misstatements. Therefore, even those systems determined to be
effective can provide only reasonable assurance of achieving their control
objectives. Furthermore, smaller reporting companies face additional
limitations. Smaller reporting companies employ fewer individuals and find it
difficult to properly segregate duties. Often, one or two individuals control
every aspect of the Company's operation and are in a position to override any
system of internal control. Additionally, smaller reporting companies tend to
utilize general accounting software packages that lack a rigorous set of
software controls.
Our
Chief Executive Officer and Chief Financial Officer evaluated the effectiveness
of the Company's internal control over financial reporting as of September 30,
2008. In making this assessment, our Chief Executive Officer and Chief Financial
Officer used the criteria set forth by the Committee of Sponsoring Organizations
of the Treadway Commission (COSO) in Internal Control -- Integrated Framework.
Based on this evaluation, our Chief Executive Officer and Chief Financial
Officer, concluded that, as of September 30, 2008, our internal control over
financial reporting was effective.
b)
Changes in Internal Control over Financial Reporting.
During
the Quarter ended September 30, 2008, there was no change in our internal
control over financial reporting (as such term is defined in Rule 13a-15(f)
under the Exchange Act) that has materially affected, or is reasonably likely to
materially affect, our internal control over financial reporting.
15
LACK
OF INDEPENDENT BOARD OF DIRECTORS AND AUDIT COMMITTEE
Management
is aware that an audit committee composed of the requisite number of independent
members along with a qualified financial expert has not yet been
established. Considering the costs associated with procuring and
providing the infrastructure to support an independent audit committee and the
limited number of transactions, Management has concluded that the risks
associated with the lack of an independent audit committee are not
justified. Management will periodically reevaluate this
situation.
LACK
OF SEGREGATION OF DUTIES
Management
is aware that there is a lack of segregation of duties at the Company due to the
small number of employees dealing with general administrative and financial
matters. However, at this time management has decided that considering the
abilities of the employees now involved and the control procedures in place, the
risks associated with such lack of segregation are low and the potential
benefits of adding employees to clearly segregate duties do not justify the
substantial expenses associated with such increases. Management will
periodically reevaluate this situation
PART
II – OTHER INFORMATION
ITEM
1. LEGAL PROCEEDINGS
We are
currently not involved in any litigation that we believe could have a material
adverse effect on our financial condition or results of operations. There is no
action, suit, proceeding, inquiry or investigation before or by any court,
public board, government agency, self-regulatory organization or body pending
or, to the knowledge of the executive officers of our company or any of our
subsidiaries, threatened against or affecting our company, our common stock, any
of our subsidiaries or of our companies or our subsidiaries' officers or
directors in their capacities as such, in which an adverse decision could have a
material adverse effect.
ITEM 1A
- Risk Factors
We have
updated the risk factors previously disclosed in our registration statement on
Form SB-2, filed November 22, 2006 (the “Form SB-2”) and in our Annual Report on
Form 10–K for the year ended December 31, 2007, which was filed with
the Securities and Exchange Commission on March 28, 2008 (the “Fiscal 2007
10–K”). We believe there are no changes that constitute material changes from
the risk factors previously disclosed in the Fiscal 2007 10–K and the Form SB-2
except as disclosed below.
Our
Common Stock Is Subject To Penny Stock Regulation
Our
shares are subject to the provisions of Section 15(g) and Rule 15g-9 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), commonly
referred to as the "penny stock" rule. Section 15(g) sets forth certain
requirements for transactions in penny stocks and Rule 15g-9(d)(1) incorporates
the definition of penny stock as that used in Rule 3a51-1 of the Exchange Act.
The Commission generally defines penny stock to be any equity security that has
a market price less than $5.00 per share, subject to certain exceptions.
Rule
3a51-1
provides that any equity security is considered to be penny stock unless that
security is: registered and traded on a national securities exchange meeting
specified criteria set by the Commission; authorized for quotation on the NASDAQ
Stock Market; issued by a registered investment company; excluded from the
definition on the basis of price (at least $5.00 per share) or the registrant's
net tangible assets; or exempted from the definition by the Commission. Since
our shares are deemed to be "penny stock", trading in the
shares
will be subject to additional sales practice requirements on broker/dealers who
sell penny stock to persons other than established customers and accredited
investors.
16
The
Liquidity Of Our Common Stock Is Seriously Limited And There Is A Limited Market
For Our Common Stock
Our stock
is currently being traded on the NASDAQ Over-The-Counter Bulletin Board, and the
liquidity of our common stock is limited. The Bulletin Board is a limited market
and subject to substantial restrictions and limitations in comparison to the
NASDAQ system. Any broker/dealer that makes a market in our stock or other
person that buys or sells our stock could have a significant influence over its
price at any given time.
II. Risks
Associated with Our Current Stage of Business
We
Depend Upon Key Management Personnel and the Loss of Any of Them Would Seriously
Disrupt Our Operations:
The
success of our company is largely dependent on the personal efforts of Scott
Landow and other key executives. The loss of the services of Scott Landow or
other key executives would have a material adverse effect on our business and
prospects. In addition, in order for us to undertake our operations as
contemplated, it will be necessary for us to locate and hire experienced
personnel who are knowledgeable in the Nutraceutical Dietary Supplement
business. Our failure to
attract and retain such experienced personnel on acceptable terms will have a
material adverse impact on our ability to grow our business.
The
nutritional supplements industry is intensely competitive. We have many
well-established competitors with substantially greater financial and other
resources than it. These factors may make it more difficult for us to
successfully implement its business plan and may adversely affect its results of
operations.
The
nutritional supplements industry is a large, highly fragmented and growing
industry, with, to management’s knowledge, no single industry participant
accounting for more than 10% of total industry retail sales. Participants
include specialty retailers, supermarkets, drugstores, mass merchants
(wholesalers), multi-level marketing organizations, mail order companies and a
variety of other smaller participants. The market is also highly sensitive to
the introduction of new products, including various prescription drugs, which
may rapidly capture a significant share of the market. Increased competition
from companies that distribute through retail or wholesale channels could have a
material adverse effect on our financial condition and results of operations. We
are a development stage business and the only revenues we have received from
product sales since inception were nominal. Accordingly, we have not been
operational long enough to experience any of the above problems. However, since
we are a development stage business, most, if not all companies in our industry
have greater financial and other resources available to them and possess
manufacturing, distribution and marketing capabilities greater than ours. In
addition, our competitors may be more effective and efficient in integrating new
products. We may not be able to compete effectively and any of the factors
listed above may cause price reductions, reduced margins and difficulties in
gaining market share.
17
ITEM 2. UNREGISTERED SALES OF
EQUITY SECURITIES AND USE OF PROCEEDS SECURITIES
During
nine months ended September 30, 2008, the Company issued 3,642,456 shares of its
common stock for $3,498,000. We also issued 1,800,000 in common stock
purchaser warrants with a strike price of $1.25 which was
expensed. The offer and sale of such shares of our common stock were
effected in reliance on the exemptions for sales of securities not involving a
public offering, as set forth in Rule 506 promulgated under the Securities Act
and in Section 4(2) of the Securities Act, based on the following:
(a) the investors confirmed to us that they were “accredited investors,” as
defined in Rule 501 of Regulation D promulgated under the Securities Act and had
such background, education and experience in financial and business matters as
to be able to evaluate the merits and risks of an investment in the securities;
(b) there was no public offering or general solicitation with respect to
the offering; (c) the investors were provided with certain disclosure
materials and all other information requested with respect to our company;
(d) the investors acknowledged that all securities being purchased were
“restricted securities” for purposes of the Securities Act, and agreed to
transfer such securities only in a transaction registered under the Securities
Act or exempt from registration under the Securities Act; and (e) a legend
was placed on the certificates representing each such security stating that it
was restricted and could only be transferred if subsequent registered under the
Securities Act or transferred in a transaction exempt from registration under
the Securities Act.
During
the three months ended March 31, 2008, the Company has issued 308,000 shares of
its common stock as consideration to consultants for services rendered and
cancelled 747,500 shares. The issuance of such shares of our common
stock were effected in reliance on the exemptions for sales of securities not
involving a public offering, as set forth in Rule 506 promulgated under the
Securities Act and in Section 4(2) of the Securities Act. A legend was
placed on the certificates representing each such security stating that it was
restricted and could only be transferred if subsequent registered under the
Securities Act or transferred in a transaction exempt from registration under
the Securities Act.
During
the three months ended June 30, 2008, the Company has issued 1,246,300 shares of
its common stock as consideration to consultants for services
rendered. The issuance of such shares of our common stock were
effected in reliance on the exemptions for sales of securities not involving a
public offering, as set forth in Rule 506 promulgated under the Securities Act
and in Section 4(2) of the Securities Act. A legend was placed on the
certificates representing each such security stating that it was restricted and
could only be transferred if subsequent registered under the Securities Act or
transferred in a transaction exempt from registration under the Securities
Act.
During
the three months ended September 30, 2008, the Company has cancelled 485,000
common shares. The issuance of such shares of our common stock were
effected in reliance on the exemptions for sales of securities not involving a
public offering, as set forth in Rule 506 promulgated under the Securities Act
and in Section 4(2) of the Securities Act. A legend was placed on the
certificates representing each such security stating that it was restricted and
could only be transferred if subsequent registered under the Securities Act or
transferred in a transaction exempt from registration under the Securities
Act.
ITEM
3. DEFAULTS UPON SENIOR SECURITIES
There
were no defaults upon senior securities during the period ended September 30,
2008.
ITEM
4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
There
were no matters submitted to the vote of securities holders during the period
ended September 30, 2008.
18
ITEM
5. OTHER INFORMATION
There is
no information with respect to which information is not otherwise called for by
this form.
ITEM
6. EXHIBITS
31.1
|
Certification
of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act
|
31.2
|
Certification
of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act.
|
32.1
|
Certification
of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley
Act.
|
32.2
|
Certification
of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley
Act.
|
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of
1934 the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
Registrant
Date:
November 14, 2008
|
Bond
Laboratories, Inc.
By:
/s/ Scott Landow
|
|
Scott
Landow
|
||
Chairman,
Chief Executive Officer (Principle Executive Officer, Principle Financial
Officer)
|
19